Not Tagged
Not Tagged
['leusm']
add'l notes: age, presenting wbc, ccipredict os in pts 55+. much of benefit w/ tx intensifications seems to be for those w/ molecular failure. discussing less intensive tx for pts 75+ or w/ comorbidities based on immunotx (as others studying as well). #ash22 #leusm #allsm (2/2)
Leukemia/cell therapy doc & AYA Leukemia Program Leader at @MSKCancerCenter w/ special interest in ALL. Indie rock & Boston sports fan. Opinions=my own.??????